A COMPARATIVE STUDY OF EFFICACY BETWEEN THIRD GENERATION ELISA AND FOURTH GENERATION TRI-DOT TEST TO DETECT SEROPREVALENCE OF HEPATITIS-C INFECTION IN PATIENTS ON HAEMODIALYSIS

  • Jolly Agarwal Junior Resident, Department of Microbiology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly, Uttar Pradesh
  • N. K. Arora Professor and UG Dean, Department of Microbiology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly, Uttar Pradesh
  • Anurag Agarwal Professor and Head, Department of Microbiology, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly, Uttar Pradesh

Abstract

Introduction: The detection of anti-HCV antibodies is based on the use of third generation
Enzyme Immunoassay (EIA) that detects antibodies directed against various HCV epitopes.
HCV TRI-DOT test is a rapid, protein A immunofiltration assay for the qualitative detection of
anti HCV antibodies in serum or plasma with a sensitivity of 100% and specificity of 91.5%.
The study was conducted to compare the efficacy between 3rd generation ELISA and 4th
generation TRI-DOT test to detect the seroprevalence of HCV and to assess the risk factors
associated with HCV infection in the patients who are on haemodialysis.
Material and Methods: The study was conducted to compare the efficacy between 3rd
generation ELISA and 4th generation TRI-DOT test to detect the seroprevalence of HCV and
to assess the risk factors associated with HCV infection in the patients who are on
haemodialysis. Sera of 150 adult CRF patients on >2 months haemodialysis tested by TRIDOT
test and then by ELISA. Demographic data of all included patients reviewed for risk
factors. Statistical analysis was performed by the SPSS program for Windows, version 17.0.
Results: Out of 150 cases, 17 were found seropositive for HCV by TRI-DOT test and 16 were
found seropositive for HCV by ELISA. One hundred and one patients were males and 49 were
females. Maximum positive patients fell in 36-55 years age group. Duration of haemodialysis,
mean blood transfusion, number of dialysis centre changed found almost double in HCV
reactive patients than in non reactive. Sensitivity of HCV TRI-DOT is 100% and specificity is
99.3%, positive predictive value is 94.1% and negative predictive value is 100% in
comparison of ELISA.
Conclusion: Seroprevalence of Hepatitis C in haemodialysis patients in our institute is 10.7%.
Risk factors for HCV infection in haemodialysis patients included duration of haemodialysis,
number of haemodialysis centre changed, number of blood transfusion unit transfused, male
gender and middle age. The sensitivity of HCV TRI-DOT is equal to HCV ELISA but the
specificity is slightly less.
Keywords: HCV Elisa, HCV tri-dot test, hepatitis C, haemodialysis

Downloads

Download data is not yet available.
Statistics
1007 Views | 764 Downloads
How to Cite
[1]
J. Agarwal, N. Arora, and A. Agarwal, “A COMPARATIVE STUDY OF EFFICACY BETWEEN THIRD GENERATION ELISA AND FOURTH GENERATION TRI-DOT TEST TO DETECT SEROPREVALENCE OF HEPATITIS-C INFECTION IN PATIENTS ON HAEMODIALYSIS”, SRMsJMS, vol. 1, no. 02, pp. 81-84, Dec. 2016.